Canada markets closed

Invitae Corporation (NVTA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
2.7800-0.0400 (-1.42%)
At close: 01:00PM EST
2.7800 0.00 (0.00%)
After hours: 04:54PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close2.8200
Bid2.7900 x 2200
Ask2.8000 x 4000
Day's Range2.7100 - 2.8100
52 Week Range1.8300 - 18.4400
Avg. Volume9,662,714
Market Cap675.251M
Beta (5Y Monthly)1.58
PE Ratio (TTM)N/A
EPS (TTM)-2.0560
Earnings DateFeb 22, 2023 - Feb 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.84
  • Motley Fool

    Why Shares of Invitae Rose 11% on Tuesday

    Shares of medical genetics testing company Invitae (NYSE: NVTA) rose 11% on Tuesday. Invitate didn't have any announcements on Tuesday, though it is presenting research this week in Nashville, Tennessee, at the National Society of Genetic Counselors conference. Invitae reported revenue of $133.5 million, up 16.7%, year over year.

  • Motley Fool

    More Likely to 5X First: Teladoc vs. Invitae

    Two stocks that could climb fivefold if they make progress toward their goals are Teladoc Health (NYSE: TDOC) and Invitae (NYSE: NVTA). Teladoc and Invitae shares both have lost more than 70% this year. Teladoc disappointed investors with two massive noncash goodwill impairment charges linked to an acquisition.

  • Simply Wall St.

    Invitae Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags

    Invitae ( NYSE:NVTA ) Third Quarter 2022 Results Key Financial Results Revenue: US$133.5m (up 17% from 3Q 2021). Net...